| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $78,349,153,860 | 29 | 100 |
| Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | 0 | $0 | 1 | $2.88M | $-2.88M |
| Zakrowski Donald A | SVP, Finance, & CAO | 0 | $0 | 2 | $3.38M | $-3.38M |
| Jonsson Patrik | EVP & President, LLY Int'l | 0 | $0 | 1 | $7.64M | $-7.64M |
| Hakim Anat | EVP, GC & Secretary | 0 | $0 | 2 | $12.96M | $-12.96M |
| LILLY ENDOWMENT INC | 10 percent owner | 0 | $0 | 24 | $78.59B | $-78.59B |
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 …
Over the last 12 months, insiders at Eli Lilly and Company have bought $0 and sold $78.35B worth of Eli Lilly and Company stock.
On average, over the past 5 years, insiders at Eli Lilly and Company have bought $126.57M and sold $21.88B worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 715 shares for transaction amount of $494,627 was made by Montarce Lucas (EVP & CFO) on 2025‑08‑15.
| 2026-11-02 | Sale | Hakim Anat | EVP, GC & Secretary | 5,000 0.0006% | $1,402.52 | $7.01M | +0.49% | |
| 2026-08-17 | Sale | Jonsson Patrik | EVP & President, LLY Int'l | 6,500 0.0007% | $1,175.10 | $7.64M | -0.11% | |
| 2026-08-10 | Sale | Zakrowski Donald A | SVP, Finance, & CAO | 2,000 0.0002% | $1,185.01 | $2.37M | -3.84% | |
| 2026-08-07 | Sale | Hakim Anat | EVP, GC & Secretary | 5,000 0.0006% | $1,190.00 | $5.95M | -0.07% | |
| 2026-06-10 | Sale | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | 2,500 0.0003% | $1,150.77 | $2.88M | +4.00% | |
| 2026-05-06 | Sale | LILLY ENDOWMENT INC | Former 10% Shareholder | 15,828 0.0017% | $995.36 | $15.75M | +18.39% | |
| 2026-01-07 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 267,069 0.0298% | $1,102.51 | $294.45M | +0.69% | |
| 2026-01-07 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 292,148 0.0327% | $1,103.48 | $322.38M | +0.69% | |
| 2026-01-05 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 1,390 0.0002% | $1,085.01 | $1.51M | +6.66% | |
| 2025-12-29 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 3,593 0.0004% | $1,085.04 | $3.9M | +2.65% | |
| 2025-12-24 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 2,629 0.0003% | $1,085.17 | $2.85M | +2.80% | |
| 2025-12-23 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 240 <0.0001% | $1,085.04 | $260,409 | +3.25% | |
| 2025-11-25 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 162,693 0.0187% | $1,096.69 | $178.42M | -2.67% | |
| 2025-11-24 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 142,307 0.016% | $1,068.52 | $152.06M | +0.98% | |
| 2025-11-21 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 105,326 0.0117% | $1,058.66 | $111.5M | +1.95% | |
| 2025-11-20 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 37,148 0.0042% | $1,051.66 | $39.07M | +3.52% | |
| 2025-11-19 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 125,284 0.014% | $1,050.49 | $131.61M | +2.87% | |
| 2025-11-19 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 167,526 0.0187% | $1,051.17 | $176.1M | +2.87% | |
| 2025-11-18 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 52,859 0.0059% | $1,034.29 | $54.67M | +4.81% | |
| 2025-11-18 | Sale | LILLY ENDOWMENT INC | 10 percent owner | 60,213 0.0067% | $1,034.78 | $62.31M | +4.81% |
| Ricks David A | President, Chair, and CEO | 546601 0.0581% | $770.37M | 2 | 6 | +46.91% |
| LECHLEITER JOHN C | former director | 160068 0.017% | $225.6M | 1 | 2 | <0.0001% |
| Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | 137660 0.0146% | $194.02M | 3 | 1 | +42.5% |
| Fyrwald J Erik | director | 74578 0.0079% | $105.11M | 1 | 0 | +59.35% |
| TAI JACKSON P | 62857 0.0067% | $88.59M | 12 | 0 | +14.08% | |
| White Anne E. | EVP & Pres, Lilly Neuroscience | 57926 0.0062% | $81.64M | 1 | 2 | +34.48% |
| Smiley Joshua L | SVP and CFO | 31524 0.0034% | $44.43M | 3 | 1 | +19.98% |
| Van Naarden Jacob | EVP & Pres., Lilly Oncology | 20562 0.0022% | $28.98M | 1 | 0 | +54.43% |
| Runge Marschall S | director | 15436 0.0016% | $21.76M | 1 | 0 | +30.13% |
| Montarce Lucas | EVP & CFO | 14685 0.0016% | $20.7M | 1 | 0 | +45.47% |
| JACKSON JAMERE | director | 9402 0.001% | $13.25M | 1 | 0 | +62.15% |
| Sulzberger Gabrielle | director | 2703 0.0003% | $3.81M | 1 | 0 | +59.35% |
| HOOVER R DAVID | director | 1500 0.0002% | $2.11M | 1 | 0 | +13.86% |
| Alvarez Ralph | director | 758 0.0001% | $1.07M | 1 | 0 | +54.43% |
| Bald Eagle Acquisition Corp | 10 percent owner | 100 0% | $140,938.00 | 1 | 0 | +7.66% |
| Tyto Acquisition Corp | 10 percent owner | 100 0% | $140,938.00 | 1 | 0 | +13.98% |
| Kearny Acquisition Corp | director | 100 0% | $140,938.00 | 1 | 0 | +18.69% |
Eli Lilly and Company (LLY) | $1,927,310,793 | 31 | 28.02% | $1,325.87B |
$364,368,632 | 29 | 9.65% | $36.8B | |
$6,224,380 | 25 | 3.58% | $640.75B | |
$23,541,811 | 22 | 6.43% | $126.14B | |
$28,542,809 | 19 | 26.39% | $505.4B |
| Increased Positions | 2,422 | +60.13% | 32M | +4.06% |
| Decreased Positions | 1,808 | -44.89% | 33M | -4.21% |
| New Positions | 661 | New | 4M | New |
| Sold Out Positions | 126 | Sold Out | 10M | Sold Out |
| Total Postitions | 4,642 | +15.24% | 789M | -0.15% |
| Lilly Endowment Inc | $103.17M | 10.11% | 95.49M | -523,985 | -0.55% | 2025-09-30 |
| Vanguard Group Inc | $88.41M | 8.66% | 81.83M | +539,763 | +0.66% | 2025-09-30 |
| Blackrock, Inc. | $71.43M | 7% | 66.12M | -254,989 | -0.38% | 2025-09-30 |
| Pnc Financial Services Group, Inc. | $55.49M | 5.44% | 51.36M | +70,209 | +0.14% | 2025-09-30 |
| State Street Corp | $37.59M | 3.68% | 34.8M | +219,500 | +0.64% | 2025-09-30 |
| Capital Research Global Investors | $27.1M | 2.66% | 25.09M | +4M | +20.87% | 2025-09-30 |
| Fmr Llc | $26.12M | 2.56% | 24.17M | -1M | -5.69% | 2025-09-30 |
| Geode Capital Management, Llc | $21.61M | 2.12% | 20M | +2M | +9.22% | 2025-09-30 |
| Morgan Stanley | $16.43M | 1.61% | 15.2M | +281,975 | +1.89% | 2025-09-30 |
| Capital World Investors | $16.17M | 1.58% | 14.97M | -3M | -15.11% | 2025-09-30 |